Adherence to psychopharmacological treatment in patients with severe and persistent mental disorders: A systematic review.

Rev Colomb Psiquiatr (Engl Ed)

Departamento de Psiquiatría, Universidad Central del Ecuador, Quito, Ecuador.

Published: August 2024

Introduction: It is known that non-adherence to psychiatric medications has harmful consequences for both patients and society.

Objective: To collect information on the incidence of non-adherence, and the factors and causes affecting adherence to psychopharmacological treatment in patients with severe and persistent mental disorders.

Methods: A systematic review of scientific articles on adult patients (>17 years) published in the last five years (2015-2020) on specialised databases such as PubMed, Scopus, Scielo and BioMed. Original articles from indexed journals with an impact factor >0.5, in English or Spanish, with an analytical, prospective, retrospective, cross-sectional and randomised design were included. Once the articles were identified, they were analysed, extracting the information necessary to answer the research questions.

Results: Fifteen articles were included. Of these, 40% (n = 6) were published in 2020, 20% (n = 3) were produced in China and 53.3% (n = 8) had an observational design. A total of 5,837 patients were included, of which 50.6% were men (n = 2,955), with moderate adherence (n = 10; 66.7%) reported in 10 investigations. Non-adherence varies from 7.7% to 60.6%. The factors that affect adherence are specific to the patient (age and sex), their family support network, and related to the disease or the treatment. The main cause of non-adherence is lack of insight.

Conclusions: Adherence to treatment with psychotropic drugs is multifactorial. Access to mental health services should be improved, with an emphasis placed on patient education and providing greater knowledge of mental illness. Interventions to promote education and interaction with the psychiatrist could be beneficial.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.rcpeng.2022.01.004DOI Listing

Publication Analysis

Top Keywords

adherence psychopharmacological
8
psychopharmacological treatment
8
treatment patients
8
patients severe
8
severe persistent
8
persistent mental
8
systematic review
8
adherence
5
patients
5
treatment
4

Similar Publications

ObjectivesPatient perception of treatment effectiveness is key to optimizing adherence. This is potentially impacted by color, yet no such studies have been conducted in asthma. This study assessed the influence of pink vs.

View Article and Find Full Text PDF

Objective: To assess the accuracy of a large language model (LLM) in measuring clinician adherence to practice guidelines for monitoring side effects after prescribing medications for children with attention-deficit/hyperactivity disorder (ADHD).

Methods: Retrospective population-based cohort study of electronic health records. Cohort included children aged 6 to 11 years with ADHD diagnosis and 2 or more ADHD medication encounters (stimulants or nonstimulants prescribed) between 2015 and 2022 in a community-based primary health care network (n = 1201).

View Article and Find Full Text PDF

[Living with psychotropic drugs: A community photovoice study in people with high treatment adherence in Southeastern Spain].

Salud Colect

October 2024

Doctora en Medicina. Catedrática de Medicina Preventiva y Salud Pública, Área de Medicina Preventiva y Salud Pública, Universidad de Alicante, Alicante, España. Área de Epidemiología y Salud Pública, Centro de Investigación Biomédica en Red (CIBERESP), Madrid, España.

Adherence to psychopharmacological treatment essentially involves a process of meaning-making. The objective of this study was to explore the experience of people undergoing chronic psychiatric treatment from the patients' perspective. In 2018, using the photovoice methodology, four sessions were conducted with the participation of 11 individuals from a community school in a socially marginalized neighborhood of a southeastern Spanish city, some of whom were also users of a social rehabilitation and integration center and a day center.

View Article and Find Full Text PDF
Article Synopsis
  • The immune system plays a crucial role in major depressive disorder (MDD), with about 30% of depressed patients exhibiting inflammation and atypical symptoms, leading to a poorer response to standard antidepressants.
  • The INSTA-MD trial is a 12-week, double-blind study assessing the effectiveness of minocycline or celecoxib as adjunct treatments for patients with MDD who have not responded to previous antidepressant trials.
  • The trial will stratify participants based on their inflammation levels (high vs. low hsCRP) and aims to determine if this stratification can help predict treatment response and improve outcomes with these immune-targeted therapies.
View Article and Find Full Text PDF

Collaborative care management (CoCM) is an evidenced based approach to psychiatric treatment in primary care, yet literature examining factors associated with program adherence is lacking. This study analyzed predictors of adherence to a CoCM model of psychopharmacological treatment of depression and anxiety in primary care by conducting a retrospective cohort analysis on Veterans referred to a large VA Medical Center's CoCM program over an 18-month period. Baseline characteristics, symptomatic assessments, and covariates of interest were collected.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!